Rogawski, David S.
Deng, Jing
Li, Hao http://orcid.org/0000-0001-8495-8467
Miao, Hongzhi
Borkin, Dmitry
Purohit, Trupta
Song, Jiho
Chase, Jennifer
Li, Shuangjiang
Ndoj, Juliano
Klossowski, Szymon
Kim, EunGi
Mao, Fengbiao
Zhou, Bo
Ropa, James
Krotoska, Marta Z.
Jin, Zhuang http://orcid.org/0000-0002-8031-5680
Ernst, Patricia
Feng, Xiaomin
Huang, Gang http://orcid.org/0000-0002-5457-5358
Nishioka, Kenichi
Kelly, Samantha
He, Miao
Wen, Bo
Sun, Duxin
Muntean, Andrew
Dou, Yali http://orcid.org/0000-0002-4040-1429
Maillard, Ivan
Cierpicki, Tomasz http://orcid.org/0000-0003-2058-0658
Grembecka, Jolanta http://orcid.org/0000-0002-6180-9095
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA244254, CA160467, T32DK007519, CA226759, CA207272)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
Leukemia and Lymphoma Society (1215-14, 6485-16, 6579-20, 8017-20, 1215-14, 6111-14, 6564-19)
Leukemia and Lymphoma Society
Leukemia and Lymphoma Society
Leukemia and Lymphoma Society
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (1R01 AG050509)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
Leukemia and Lymphoma Society
Leukemia and Lymphoma Society
Leukemia and Lymphoma Society
Article History
Received: 14 August 2020
Accepted: 13 April 2021
First Online: 14 May 2021
Competing interests
: J.G., T.C., D.R., H.L., J. D., S.K., H.M., T.P., E.K., M.S., D.B., and J. Z. are co-inventors on patent applications covering ASH1L inhibitors. T.C. and J.G. received prior research support from Kura Oncology Inc. for unrelated project; served as consultants in Kura Oncology and have equity ownership in the company. The remaining authors declare that they have no competing interests with this study.